Cafedrine

This classification denotes a cns stimulant with the molecular formula C18H23N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0UYY5V4U2Q, chemically known as 1h-purine-2,6-dione, 3,7-dihydro-7-(2-((2-hydroxy-1-methyl-2-phenylethyl)amino)ethyl)-1,3-dimethyl- (van) but generally known as cafedrine, which bears US NIH Compound Identifier 71740. European Medicines Agency schedules Cafedrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06044MIG. The term CAFEDRINE is an International Non-Proprietary Name. World Health Organization schedules cafedrine in its Anatomical Therapeutic Chemical (ATC) Classification. CAFEDRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cafedrine under HS 29395900 and SITC 54145. As of Q4 2014, CAFEDRINE remains the US FDA Preferred Term for this commodity. Cafedrine bears US NLM identifiers UMLS ID C0068978 and NCI Concept Code C76026. SMILES: OC(C(NCCN1C2C(N(C(=O)N(C2=O)C)C)NC1)C)C1CCCCC1.